Black Friday saleUp to 70% OFF
222

U2BIO CO., LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

221800 chart


Full chart

Key stats


Market capitalization
‪31.77 B‬ KRW
Dividend yield (indicated)
1.07%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪645.90 M‬ KRW
Revenue (FY)
‪30.79 B‬ KRW
Shares float
‪11.27 M‬
Beta (1Y)
−0.23

Employees


Employees (FY)
88
Change (1Y)
−15 −14.56%
Revenue / Employee (1Y)
‪268.73 K‬ KRW
Net income / Employee (1Y)
‪5.64 K‬ KRW

About U2BIO CO., LTD.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Jin-Tae Kim
Website
u2bio.co.kr
Headquarters
Seoul
Founded
2009
ISIN
KR7221800006
FIGI
BBG009H6FGT5
U2Bio Co., Ltd. engages in the provision of in vitro diagnostics and medical information technology (IT) services. It operates through the following business areas: In vitro diagnostics services, Medical IT Solutions, and New Business. In vitro diagnostics business offers general diagnostic tests, molecular diagnostic tests, and research authorization clinical services. The Medical IT solution business provides medical practitioner-centered health examination, specialized medical examination and diagnostic equipment, and electronic medical record interworking solutions. The New Business area focuses on clinical trial services and personalized healthcare solutions. The company was founded on January 2, 2009 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 221800 is 2,935 KRW — it has decreased by −3.02% in the past 24 hours. Watch U2BIO CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange U2BIO CO., LTD. stocks are traded under the ticker 221800.
221800 stock has fallen by −2.15% compared to the previous week, the month change is a −11.94% fall, over the last year U2BIO CO., LTD. has showed a −50.92% decrease.
221800 reached its all-time high on Nov 3, 2023 with the price of 10,950 KRW, and its all-time low was 2,600 KRW and was reached on Nov 14, 2024. View more price dynamics on 221800 chart.
See other stocks reaching their highest and lowest prices.
221800 stock is 18.41% volatile and has beta coefficient of −0.23. Track U2BIO CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is U2BIO CO., LTD. there?
Today U2BIO CO., LTD. has the market capitalization of ‪31.77 B‬, it has decreased by −3.57% over the last week.
Yes, you can track U2BIO CO., LTD. financials in yearly and quarterly reports right on TradingView.
221800 net income for the last quarter is ‪−449.61 M‬ KRW, while the quarter before that showed ‪−25.66 M‬ KRW of net income which accounts for ‪−1.65 K‬% change. Track more U2BIO CO., LTD. financial stats to get the full picture.
Yes, 221800 dividends are paid annually. The last dividend per share was 30.00 KRW. As of today, Dividend Yield (TTM)% is 1.07%. Tracking U2BIO CO., LTD. dividends might help you take more informed decisions.
U2BIO CO., LTD. dividend yield was 0.57% in 2023, and payout ratio reached 47.92%. The year before the numbers were 1.93% and 9.60% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 28, 2024, the company has 88.00 employees. See our rating of the largest employees — is U2BIO CO., LTD. on this list?
Like other stocks, 221800 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade U2BIO CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So U2BIO CO., LTD. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating U2BIO CO., LTD. stock shows the neutral signal. See more of U2BIO CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.